|
|
 |
|
DRRX: Durect Cp - Stock News |
Enter Ticker:
|
|
| Nov 23, 2009 |
DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference |
| Oct 29, 2009 |
DURECT Corporation Announces Third Quarter 2009 Financial Results |
| Oct 26, 2009 |
DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call |
| Sep 25, 2009 |
Durect Up 16.2% Since SmarTrend's Buy Recommendation |
| Sep 18, 2009 |
BiomedReports: News and FDA Updates for ImmunoCellular (OTC:IMUC), Valeant (NYSE:VRX), DURECT (Nasdaq:DRRX), Arena Pharma (Nasdaq:ARNA) |
| Sep 17, 2009 |
DURECT Corporation to Participate in Upcoming Healthcare Conferences |
| Sep 16, 2009 |
Pandesa ShareVault Enables Secure, Real-time Due Diligence for Biopharmaceutical Partnering |
| Sep 14, 2009 |
DURECT Corp declares sale of 4.44m shares of common stock |
| Sep 14, 2009 |
Durect To Raise $10 Million From Share Sale |
| Sep 11, 2009 |
PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, September 11, 2009: S, DIET, DRRX, COCO, USAP and IOSP. |
| Sep 11, 2009 |
DURECT Announced Selling Common Stock Worth $10 Million To Venrock (DRRX) |
| Sep 11, 2009 |
DURECT Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million |
| Aug 27, 2009 |
PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, August 27, 2009: FCEL, FMBI, CLNE, TMRK, DRRX and POZN. |
| Aug 27, 2009 |
Durect Corp. Signed Agreement To Supply Painkiller to King (DRRX,PTIE,KG) |
| Aug 27, 2009 |
DRRX: Long Term Excipient Supply Agreement w/King Pharmaceuticals |
| |
| ZACKS COMMENTARY FOR DRRX |
| Nov 23, 2009 | Zacks Equity Research: Report for DRRX | | Sep 24, 2009 | Zacks Blog: King Launches Embeda | | Sep 04, 2009 | Zacks Blog: Advisory Panel to Review Acurox | | Aug 05, 2009 | Zacks Blog: Zacks Bull and Bear of the Day Highlights: Durect Corp., Genzyme, Caterpillar, Grainger and Texas Instruments | | Aug 05, 2009 | Bull of the Day: Durect Corporation - DRRX | | Jul 08, 2009 | Zacks Blog: Update On King’s Remoxy | | Jun 16, 2009 | Zacks Blog: Durect Offers Long-Term Upside | | May 07, 2009 | Zacks Blog: Durect at Attractive Entry Point | | Mar 05, 2009 | Zacks Blog: Better Times Ahead for Durect | | Feb 13, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Durect Corp., Alpharma, Journal Communications, Inc., Alexion Pharmaceuticals Inc. and Procter & Gamble. | | Feb 12, 2009 | Zacks Blog: Buy Durect Shares Up to $5 | | Dec 15, 2008 | Zacks Blog: Durect to Rebound from Setback |
|
|
Sponsored Links 
0.09